Transaction Price of $9.10 Per Share Represents Compelling 89% Premium to CTI s Closing Stock Price on May 9, 2023
SEATTLE, May 10, 2023 /PRNewswire/ CTI BioPharma , a commercial. | May 10, 2023
/PRNewswire/ CTI BioPharma (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted.